MedTrace Logo

A Retrospective Clinical Study on the First-line Maintenance Treatment of PTCL With Chidamide.

NCT05967949 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2023-08-01

No results posted yet for this study

Summary

The efficacy and safety of chidamide in first-line maintenance therapy for PTCL will be assessed through a retrospective case analysis.

Conditions

  • PTCL

Interventions

DRUG

chidamide

This subset of patients received chidamide as first-line maintenance therapy.

Sponsors & Collaborators

  • The First Affiliated Hospital with Nanjing Medical University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-01
Primary Completion
2026-04-01
Completion
2028-04-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05967949 on ClinicalTrials.gov